Literature DB >> 23940075

The role of TLR2 and 4 in Behçet's disease pathogenesis.

Noha Seoudi1, Lesley A Bergmeier, Eleni Hagi-Pavli, David Bibby, Michael A Curtis, Farida Fortune.   

Abstract

TLRs are PRRs that play a pivotal role in sensing exogenous pathogens and endogenous danger signals. Their role in the pathogenesis of inflammatory and immune-related diseases is gradually being unravelled. TLR2 and TLR4 are capable of sensing the oral microbial community, which is considered a potential trigger for Behçet's disease (BD). This study aimed to investigate the expression and function of TLR2 and TLR4 in the oral mucosa of BD. A total of 87 patients was included: 55 BD, 24 healthy controls and eight recurrent aphthous stomatitis. Total RNA was purified from non-lesional oral mucosal brush biopsies and analysed for the presence of TLR2 and TLR4 mRNA, along with their splice variants. The response of peripheral blood mononuclear cells to classical TLR2 and TLR4 agonists was also investigated. TLR2b, TLR2d, TLR2e, TLR4.3 and TLR4.4 were significantly elevated in relapsed BD. A significant defect in the response to cognate agonists of TLR1/2 heterodimer and TLR4 was also observed in BD. The expression of unusual splice variants of TLR2 and TLR4 might explain the observed defect in these receptors' function in BD.

Entities:  

Keywords:  Behçet’s disease; TLR; Toll-like receptors; oral mucosa

Mesh:

Substances:

Year:  2013        PMID: 23940075     DOI: 10.1177/1753425913498042

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  15 in total

Review 1.  Mucosal Lesions in an Allergy Practice.

Authors:  John J Kohorst; Alison J Bruce; Rochelle R Torgerson
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

Review 2.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

3.  The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis.

Authors:  Bunsoon Choi; Chang-Hee Suh; Hyoun-Ah Kim; Hasan M Sayeed; Seonghyang Sohn
Journal:  Mediators Inflamm       Date:  2017-03-09       Impact factor: 4.711

4.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

5.  MicroRNA Expression Profiling in Behçet's Disease.

Authors:  Antonio Puccetti; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818

6.  Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.

Authors:  Tim van der Houwen; Jan van Laar
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

7.  The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis.

Authors:  Noha Seoudi; Lesley A Bergmeier; Eleni Hagi-Pavli; David Bibby; Farida Fortune
Journal:  J Oral Microbiol       Date:  2015-06-05       Impact factor: 5.474

8.  Two Genetic Variations in the IRF8 region are associated with Behçet's disease in Han Chinese.

Authors:  Yanni Jiang; Hong Wang; Hongsong Yu; Lin Li; Dengfeng Xu; Shengping Hou; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

Review 9.  Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.

Authors:  Md Samiul Hasan; Lesley Ann Bergmeier; Harry Petrushkin; Farida Fortune
Journal:  J Immunol Res       Date:  2015-10-11       Impact factor: 4.818

10.  Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander T H Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2018-07-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.